Adalimumab persistence for inflammatory bowel disease in veteran and insured cohorts.

Shail M. Govani(South Texas Veterans Health Care System), Akbar K. Waljee(University of Michigan), Jacqueline A. Pugh(The University of Texas at San Antonio Health Science Center), Ryan W. Stidham(University of Michigan), Rachel Lipson, Peter Higgins(Michigan Medicine), Wyndy L. Wiitala, Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Sameer D. Saini(University of Michigan), Mohamed Noureldin
PubMed
December 1, 2018
Cited by 7


Related Papers